艾松乐 AEMD 深 沪
等待开盘 12-16 09:30:00 美东时间
3.05
-0.350
-10.29%
华盛通- 最 高3.38
- 今 开3.38
- 成交量 7.26万股
- 最 低 3.05
- 昨 收 3.40
- 总市值 232.20万
- 52周最高 84.40
- 市盈率 静 --
- 换手率 9.53%
- 52周最低 3.05
- 委 比 54.55%
- 总股本 76.13万
- 历史最高 432000.00
- 量 比 0.65
- 振 幅 9.71%
- 历史最低 3.05
- 每 手 1
- 风险率 17.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why American Eagle Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Shares of American Eagle Outfitters Inc (NYSE:AEO) rose sharply in pre-market t...
12-03 17:51
Aethlon Medical Announces Publication Of Pre-Clinical Long COVID Study On bioRxiv
Results Support the Further Investigation of the Hemopurifier in Long COVIDSAN DIEGO, Dec. 2, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to
12-02 21:26
Aethlon Medical shares are trading higher. The company reported Q2 financial results.
Aethlon Medical shares are trading higher. The company reported Q2 financial re...
11-13 22:15
Aethlon Medical Q2 EPS $(3.74) Misses $(3.66) Estimate
Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(3.74) per share which missed the analyst consensus estimate of $(3.66) by 2.1 percent. This is a 133.75 percent decrease over losses of $(1.60) per share from
11-13 05:16
Earnings Scheduled For November 12, 2025
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
11-12 19:11
What to Expect from Aethlon Medical's Earnings
Aethlon Medical (NASDAQ:AEMD) is preparing to release its quarterly earnings on...
11-12 03:03
Aethlon Medical Regains Nasdaq Compliance
On November 5, 2025, Aethlon Medical, Inc., a Nevada corporation (the "Company") received a letter from the Nasdaq Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it
11-06 22:22
Aethlon Medical Faces Nasdaq Non-Compliance Notice
Aethlon Medical ( ($AEMD) ) has provided an update. On October 16, 2025, Aethlo...
10-23 04:57
ENDRA Life Sciences Gains Momentum With Crypto-Focused Treasury Plan
ENDRA Life Sciences Inc. (NASDAQ: NDRA) announced $4.9M in funding to launch a digital asset treasury strategy.
10-14 00:24
